Background The literature on antiplatelet therapy for peripheral artery disease has
historically been summarized inconsistently, leading to conflict between international …

New Technologies for the Treatment of Peripheral Artery Disease - Abstract - Europe PMC Sign
in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …

Synthetic chemically modified mRNAs (modRNA) encoding vascular endothelial growth
factor (VEGF) represents an alternative to gene therapy for the treatment of ischemic …

(1) This study tests hypothesis whether extracorporeal shock wave (ECSW) therapy
effectively salvages mouse critical limb ischemia (CLI). In vitro result demonstrated that the …

Aging is a biological process with effects at the molecular, cellular, tissue, organ, system,
and organismal levels and is characterized by decline in physical function and higher risks …

Purpose We aimed to evaluate the impact of intrinsic coagulation factors and hemostatic
markers of endothelial dysfunction on complications in patients with atherosclerotic …

Animal studies have indicated that olfactomedin 2 (OLFM2) is involved in the process of
vascular remolding. The aim of the present study was to investigate circulating OLFM2 levels …

Objectives Few data are available on the association between a different entity of platelet
inhibition on antiplatelet treatment and clinical outcomes in patients with peripheral artery …

Background Hemodialysis (HD) patients with peripheral arterial disease (PAD) are at
heightened risk of adverse vascular events, and aspirin positively affects those outcomes …

The possibility of injectable biomaterials being used in the therapy of peripheral artery
disease (PAD) is investigated in this article. We conducted a thorough review of the literature …